Dividend compounder review
HLN
Haleon plc · NYSE · US
Healthcare · Drug Manufacturers - Specialty & Generic
Score79.90/100
Confidence100.00/100
DecisionWatchlist
RatingHigh Quality Watchlist Candidate
Quality breakdown
Dividend Reliability
10.9 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
20.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
24.0 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
15.0 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
10.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years3
Dividend Yield2.14%
Payout Ratio37.1%
Dividend Cut 5YNo
Net Income$1.7B
Free Cash Flow$2.2B
FCF Covers DividendYes
Debt / Equity0.52
P/E18.6
Revenue Growth 5Y1.7%
Net Margin15.1%
ROE10.3%
Price vs Trend-7.0%
3Y Return14.4%
5Y Return38.1%
CurrencyUSD
Review flags
Price currency USD differs from financial currency GBP.
Dividend history is short: 3 completed years.
Less than five years of weekly price history available.
Activity record
Less than five years of weekly price history available.
Score 79.9/100, decision Watchlist.
Payment changed from 0.059 to 0.131.
Recorded dividend payment for Haleon plc.
Payment changed from 0.117 to 0.059.
Recorded dividend payment for Haleon plc.
Payment changed from 0.051 to 0.117.
Recorded dividend payment for Haleon plc.
Payment changed from 0.106 to 0.051.
Recorded dividend payment for Haleon plc.
Payment changed from 0.046 to 0.106.
Recorded dividend payment for Haleon plc.
Payment changed from 0.058 to 0.046.
Recorded dividend payment for Haleon plc.
Recorded dividend payment for Haleon plc.